Allurion Technologies (ALURD) Change in Receivables (2022 - 2026)
Allurion Technologies' (ALURD) quarterly Change in Receivables came in at -$365000.0 in Q1 2026, down 141.34% YoY from $883000.0 in Q1 2025, and down 126.32% on a QoQ basis from $1.4 million in Q4 2025.
Allurion Technologies (ALURD) Change in Receivables (2022 - 2026) Analysis & Trends
Allurion Technologies (ALURD) has 5 years of Change in Receivables data on file, last reported at -$365000.0 in Q1 2026.
- Quarterly Change in Receivables fell 141.34% year-over-year to -$365000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.1 million (up 67.42% YoY) and the FY2025 annual result came in at -$844000.0, up 90.6% from the prior year.
- Change in Receivables fell to -$365000.0 in Q1 2026, from $1.4 million in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $9.0 million in Q4 2022 to a low of -$2.8 million in Q3 2024.
- A 5-year average of $120666.7 and a median of -$865000.0 in 2025 frame the typical range for Change in Receivables.
- Annual changes were most pronounced in 2023 — Change in Receivables soared 185.98% — and 2024, when it sank 491.8%.
- Tracing ALURD's Change in Receivables over 5 years: stood at $9.0 million in 2022, then slumped by 128.52% to -$2.6 million in 2023, then jumped by 30.68% to -$1.8 million in 2024, then jumped by 178.01% to $1.4 million in 2025, then tumbled by 126.32% to -$365000.0 in 2026.
- The last three Change in Receivables figures came in at -$365000.0 (Q1 2026), $1.4 million (Q4 2025), and -$865000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 386.00 Mn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 177.00 Mn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 287.00 Mn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 46.00 Mn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 10.20 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 172.10 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 79.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | - |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | -90.00 Mn |
| 10 | Allurion Technologies | 49.18 Mn | 44.13 Mn | 1.23 Mn | -365,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -365,000.00 |
| Mar 31, 2026 | -365,000.00 |
| Dec 31, 2025 | 1.39 Mn |
| Dec 31, 2025 | 1.39 Mn |
| Sep 30, 2025 | -865,000.00 |
| Sep 30, 2025 | -865,000.00 |
| Jun 30, 2025 | -2.25 Mn |
| Jun 30, 2025 | -2.25 Mn |
| Mar 31, 2025 | 883,000.00 |
| Mar 31, 2025 | 883,000.00 |
| Dec 31, 2024 | -1.78 Mn |
| Dec 31, 2024 | -1.78 Mn |
| Sep 30, 2024 | -2.79 Mn |
| Sep 30, 2024 | -2.79 Mn |
| Jun 30, 2024 | -2.74 Mn |
| Jun 30, 2024 | -2.74 Mn |
| Mar 31, 2024 | -1.67 Mn |
| Mar 31, 2024 | -1.67 Mn |
| Dec 31, 2023 | -2.57 Mn |
| Dec 31, 2023 | -2.57 Mn |